NEW YORK (GenomeWeb) – Personal Genome Diagnostics said today that it has raised $75 million in a Series B financing round led by new investor Bristol-Myers Squibb and previous investor New Enterprise Associates.

New and existing investors including Inova Strategic Investments, Co-win Healthcare Fund, Helsinn Investment Fund, Windham Venture Partners, and Maryland Venture Fund participated in the financing along with undisclosed investors.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.